Royce & Associates LP Surmodics Inc Transaction History
Royce & Associates LP
- $10.3 Billion
- Q4 2024
A detailed history of Royce & Associates LP transactions in Surmodics Inc stock. As of the latest transaction made, Royce & Associates LP holds 42,305 shares of SRDX stock, worth $1.31 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
42,305
Previous 66,205
36.1%
Holding current value
$1.31 Million
Previous $2.57 Million
34.75%
% of portfolio
0.02%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding SRDX
# of Institutions
141Shares Held
12.1MCall Options Held
31.4KPut Options Held
13.2K-
Black Rock Inc. New York, NY1.17MShares$36.3 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.01MShares$31.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA803KShares$24.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY675KShares$20.9 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X0454KShares$14.1 Million0.02% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $434M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...